In this regard, we first evaluated STAT3 activity in A549 and SW900 lung cancer cells, compared to normal cells (HFL-1) (Figure 4A), observing a significant increase in basal STAT3 signaling in cancer cells, accompanied by higher levels of survivin expression. The gene discussed is BIRC5; the disease is lung cancer.